The slip
PARKINSON RECEIPTno. 4756
21 Oct 2026, 00:52 UTColigodendrocytes, braak
predictionKCNH5 in oligodendrocytes tracks Braak Lewy-body stage
registerede52065ef788fbd39
discovery-0.14 p=0.714 n=9
replication+0.03 p=0.929 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.14, p 0.714)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT42d66aa70083d50aac122d0a…
follows 14a59889f7e1…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 4756: KCNH5 in oligodendrocytes, braak
- power
- full sample -0.00 (p 0.990, n 18), 95% CI -0.47 to +0.46. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.901, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: +0.03 (p 0.894, n 18). could be the mix.
- skeptic
- leave-one-out range -0.12 to +0.14, sign flips 10; without severely affected donors -0.00 (p 0.990, n 18). fragile.
- cell type
- strongest in dopamine neurons: +0.61 (p 0.0069, n 18) vs -0.00 in oligodendrocytes. proposing dopamine neurons.
- axis
- no measure beats "tracks Braak Lewy-body stage" for KCNH5 in oligodendrocytes.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up KCNH5 · dopamine neurons · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) +0.35 p 0.214 (needs p < 4.1e-4)